SLC22A5 and chronic myelogenous leukemia, BCR-ABL1 positive: We identified five SNVs associated with CML predisposition, with some variants increasing disease risk, including TT genotype ABCB1 (rs1045642), and others showing a protective effect (GG genotype SLC22A5 rs274558).